[1]
Adelusi, T.I. et al. 2021. Molecular Docking Assessment of Clinically Approved Antiviral Drugs against Mpro, Spike Glycoprotein and Angiotensin Converting Enzyme-2 Revealed Probable Anti-SARS-CoV-2 Potential: doi.org/10.26538/tjnpr/v5i4.30. Tropical Journal of Natural Product Research (TJNPR). 5, 4 (Mar. 2021), 778–791.